Dynamic Technology Lab Private LTD Curis Inc Transaction History

Dynamic Technology Lab Private LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.71 - $2.43 $28,897 - $98,901	-40,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $26,934 - $59,815	11,660 Added 40.15%	40,700 $97,000
Q4 2021 Feb 14, 2022	SELL	$4.45 - $8.09 $26,308 - $47,828	-5,912 Reduced 16.91%	29,040 $138,000
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $146,135 - $186,354	21,057 Added 151.54%	34,952 $274,000
Q2 2021 Aug 13, 2021	BUY	$7.45 - $16.27 $103,517 - $226,071	13,895 New	13,895 $112,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.